Skip to content

DR. VANDEVONDELE - DANEELS

Active
Private limited companyfounded 2022active for 4 yearsRodonkstraat 32, 9030 Gent, BelgiumKBO/BCE: BE 0787.997.514

From the official registers: KBO 4 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR. VANDEVONDELE - DANEELS has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €23,500 and a net result of €16,632. Equity has been growing by about 12% per year since 2022. Its solvency ranks better than 23% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
DR. VANDEVONDELE - DANEELSActiveChecked score 93/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 04-07-2022 Normal situation
Legal form
Private limited company
Registered office
Rodonkstraat 32, 9030 Gent
Activity
General medical practice NACE 86210
Establishment unit
2.335.842.548 9030 Gent, since 04-07-2022
Financial year end
31 December
Peppol
Reachable since 20-12-2024
Company details

Board and ownership

Board
Board & ownership

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€48,032
▼ 5.5%
Turnover
≈ €150,000
estimated
Profit
€16,632
▼ 52.1%
Equity
€23,500
=
Total assets
€89,325
▲ 20.4%
2025 accounts filed 126 days before the deadline
Filed on 27-03-2026PDF
Financials
Score breakdownraises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.69, cash €72,983Figures for financial year 2025 (filed on 27-03-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 40% of micro companies in human health (NACE 86)
Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Strong
Solvency 51-6
equity 26.3% of total assets
Liquidity 71+6
short-term debt 55.9% · cash 81.7%
Profitability 92-8
return on assets 18.6%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026highest value 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €2,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.69 (1.36 in 2024), above the usual 1.5. Short-term debt is 55.9% and cash 81.7% of total assets. However, 73.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 24% of them on solvency, 52% on liquidity, 49% on profitability and 37% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.69, cash €72,983
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Figures for financial year 2025 (filed on 27-03-2026)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 20678 sector peers (2025).
NBB · sector comparison
Position among 20678 sector peers
Solvency
better than 23%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-03-2026, 126 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
126 days early
2024
21 days early
2023
36 days early
2022
30 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 4 accounts on average 38 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 3 July (3 of the last 4 filed years within 58 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2022.
KBO publications

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about DR. VANDEVONDELE - DANEELS

What is the company number of DR. VANDEVONDELE - DANEELS?
The company number of DR. VANDEVONDELE - DANEELS is 0787.997.514. The VAT number is the same number with BE in front: BE 0787.997.514.
Where is DR. VANDEVONDELE - DANEELS based?
The registered office is at Rodonkstraat 32, 9030 Gent.Company details
What does DR. VANDEVONDELE - DANEELS do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. VANDEVONDELE - DANEELS?
The legal form of DR. VANDEVONDELE - DANEELS is Private limited company (BV).
When was DR. VANDEVONDELE - DANEELS founded?
DR. VANDEVONDELE - DANEELS was founded on 04-07-2022.
Is DR. VANDEVONDELE - DANEELS still active?
Yes, DR. VANDEVONDELE - DANEELS is an active enterprise in the KBO register.
What is the turnover of DR. VANDEVONDELE - DANEELS?
The turnover in financial year 2025 is ≈ €150,000. This figure is estimated from the gross margin of €48,032 and 47 comparable companies (NACE 86). It probably lies between €110,000 and €210,000.Financials
Is DR. VANDEVONDELE - DANEELS profitable?
In financial year 2025, DR. VANDEVONDELE - DANEELS made a profit of €16,632.
Where can I find the annual accounts of DR. VANDEVONDELE - DANEELS?
DR. VANDEVONDELE - DANEELS filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of DR. VANDEVONDELE - DANEELS due?
DR. VANDEVONDELE - DANEELS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Comparable companies

These companies have the same main activity as DR. VANDEVONDELE - DANEELS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €81,400 and €98,400, founded in 2022.

CompanyTotal assetsGross margin
DR. VANDEVONDELE - DANEELS Gent€89,325€48,032
Dr. Liesbeth Veelaert, Huisarts Gent€86,112€52,776
Dr. Laura Cox Ravels€86,960€50,985
MORAY MEDICAL Chaudfontaine€96,093€50,096
DOCTEUR M.C. Anderlecht€81,353€45,789
DR. STEPHANIE PAUWELS Kasterlee€97,408€51,031
Dokter Lore Goetschalckx Mol€98,395€47,988
Full comparison

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure